|
Balance Sheet (USD $)
|
Sep. 30, 2013
|
Dec. 31, 2012
|
| Current Assets: |
|
|
| Cash and cash equivalents |
$ 14,871,000 |
$ 13,486,543 |
| Marketable securities (note 3) |
100,000 |
100,000 |
| Prepaid expenses and other current assets (note 4) |
523,117 |
188,808 |
| Total Current Assets |
15,494,117 |
13,775,351 |
| Restricted Cash Equivalents (note 16) |
509,179 |
1,091,801 |
| Equipment, Net (note 6) |
70,419 |
52,156 |
| Total Assets |
16,073,715 |
14,919,308 |
| Current Liabilities: |
|
|
| Accounts payable and accrued expenses (note 7) |
750,242 |
851,837 |
| Deferred Research and Development Arrangement (note 8) |
1,165,429 |
1,626,000 |
| Other Liabilities (note 9) |
114,588 |
65,417 |
| Warrant Liabilities (note 13) |
4,192,216 |
2,842,065 |
| Total Liabilities |
6,222,475 |
5,385,319 |
| Commitments and Contingencies (note 16) |
|
|
| Stockholders' Equity (note 11): |
|
|
| Preferred stock, par value $0.0001, 100,000,000 authorized shares, none issued and outstanding |
0 |
0 |
| Common stock, par value $0.0001, 500,000,000 authorized shares, 134,457,144 and 119,443,194 issued and 134,442,939 and 119,428,989 oustanding |
13,446 |
11,944 |
| Additional paid-in capital |
79,957,246 |
72,861,738 |
| Accumulated deficit during the development stage |
(70,091,042) |
(63,311,283) |
| Treasury stock, 14,205 shares, at cost |
(28,410) |
(28,410) |
| Total Stockholders' Equity |
9,851,240 |
9,533,989 |
| Total Liabilities and Stockholders' Equity |
$ 16,073,715 |
$ 14,919,308 |